Plug Power Ships First Production Progen Engines for Electric Vehicle Range Extenders
Feb 08, 2017 12:01 pm UTC| Business
LATHAM, N.Y., Feb. 08, 2017 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, has shipped the first production ProGen fuel cell engines for use in electric...
Apricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference
Feb 08, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 08, 2017 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer,...
Brink’s Reports Higher Fourth-Quarter, Full-Year Earnings
Feb 08, 2017 12:01 pm UTC| Business
Improved Performance in U.S., Latin America and Mexico Drive Fourth-Quarter Profit GrowthGAAP EPS: Fourth Quarter $.28 vs ($.07); Full Year $.72 vs ($.19)Non-GAAP EPS: Fourth Quarter $.87 vs $.55; Full Year $2.24 vs $1.69 ...
ClubCorp Acquires Eagle’s Nest Country Club
Feb 08, 2017 12:01 pm UTC| Business
DALLAS, Feb. 08, 2017 -- ClubCorp – The World Leader in Private Clubs® (NYSE:MYCC) – announces the acquisition of Eagle’s Nest Country Club, a premier member-owned country club located in Maryland, just north of...
Inspire grows online patient community to one million strong
Feb 08, 2017 12:01 pm UTC| Business
ARLINGTON, Va., Feb. 08, 2017 -- Leading healthcare social network Inspire has reached the milestone of one million registered members. “It’s gratifying and humbling to see the community’s growth,” said Brian Loew,...
Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR®
Feb 08, 2017 12:00 pm UTC| Business
ROCKVILLE, Md., Feb. 08, 2017 -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases,...
Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR®
Feb 08, 2017 12:01 pm UTC| Business
ROCKVILLE, Md., Feb. 08, 2017 -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases,...